These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 18048875)

  • 1. Disabling pansclerotic morphea of childhood poses a high risk of chronic ulceration of the skin and squamous cell carcinoma.
    Wollina U; Buslau M; Heinig B; Petrov I; Unger E; Kyriopoulou E; Koch A; Köstler E; Schönlebe J; Haroske G; Doede T; Pramatarov K
    Int J Low Extrem Wounds; 2007 Dec; 6(4):291-8. PubMed ID: 18048875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower lip squamous cell carcinoma in disabling pansclerotic morphea of childhood.
    Petrov I; Gantcheva M; Miteva L; Vassileva S; Pramatarov K
    Pediatr Dermatol; 2009; 26(1):59-61. PubMed ID: 19250408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disabling pansclerotic morphea: clinical presentation in two adults.
    Maragh SH; Davis MD; Bruce AJ; Nelson AM
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 1):S115-9. PubMed ID: 16021158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children.
    Roldan R; Morote G; Castro Mdel C; Miranda MD; Moreno JC; Collantes E
    J Rheumatol; 2006 Dec; 33(12):2538-40. PubMed ID: 17143989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incapacitating pansclerotic morphea in childhood].
    Ferrandiz C; Henkes J; González J; Peyri J
    Med Cutan Ibero Lat Am; 1981; 9(5):377-82. PubMed ID: 7038353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pansclerotic morphea in childhood: a case report.
    Doede T; Wollina U; Hindermann W; Schier F; Bondartschuk M
    Pediatr Surg Int; 2003 Jul; 19(5):406-8. PubMed ID: 12827414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma in pansclerotic morphea of childhood.
    Wollina U; Buslau M; Weyers W
    Pediatr Dermatol; 2002; 19(2):151-4. PubMed ID: 11994182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous squamous cell carcinoma arising within generalised morphea.
    Saleh DB; Williams AM; Smith IM
    J Plast Reconstr Aesthet Surg; 2011 Jun; 64(6):e149-52. PubMed ID: 21420372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marjolin's ulcer: the importance of surgical management of chronic cutaneous ulcers.
    Asuquo M; Ugare G; Ebughe G; Jibril P
    Int J Dermatol; 2007 Oct; 46 Suppl 2():29-32. PubMed ID: 17958627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral sildenafil in skin ulcers secondary to systemic sclerosis.
    Della Rossa A; Doveri M; D'Ascanio A; Tavoni A; Consensi A; Neri R; Bazzichi L; Bombardieri S
    Scand J Rheumatol; 2011; 40(4):323-5. PubMed ID: 21639825
    [No Abstract]   [Full Text] [Related]  

  • 11. Marjolin's ulcer: Sequelae of mismanaged chronic cutaneous ulcers.
    Asuquo ME; Ikpeme IA; Ebughe G; Bassey EE
    Adv Skin Wound Care; 2010 Sep; 23(9):414-6. PubMed ID: 20729647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe refractory fingertip ulcerations in a patient with scleroderma: successful treatment with sildenafil.
    Colglazier CL; Sutej PG; O'Rourke KS
    J Rheumatol; 2005 Dec; 32(12):2440-2. PubMed ID: 16331780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disabling pansclerotic morphea of childhood--unusual case and management challenges.
    Forsea AM; Cretu AN; Ionescu R; Giurcaneanu C
    J Med Life; 2008; 1(3):348-54. PubMed ID: 20108512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral sildenafil for the treatment of Raynaud's phenomenon and digital ulcers secondary to systemic sclerosis.
    Gore J; Silver R
    Ann Rheum Dis; 2005 Sep; 64(9):1387. PubMed ID: 16100356
    [No Abstract]   [Full Text] [Related]  

  • 15. Metastatic Squamous Cell Carcinoma in a Patient with Disabling Pansclerotic Morphea of Childhood.
    Ruiz-Matta JM; Flores-Bozo LR; Dominguez-Cherit J
    Pediatr Dermatol; 2017 Jul; 34(4):e164-e167. PubMed ID: 28543434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.
    Soh HJ; Samuel C; Heaton V; Renton WD; Cox A; Munro J
    Rheumatol Int; 2019 May; 39(5):933-941. PubMed ID: 30838436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disabling pansclerotic morphoea of childhood.
    Jamalpur I; Mogili HR; Koratala A
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29455178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoma in plantar ulcers of leprosy patients: a report of 4 cases from Turkey.
    Ozkan T; Yuksel A; Saylan T; Erding N; Sutlas M; Mat C
    Lepr Rev; 1988 Dec; 59(4):356-7. PubMed ID: 3244298
    [No Abstract]   [Full Text] [Related]  

  • 19. Ulcers caused by bullous morphea treated with tissue-engineered skin.
    Martin LK; Kirsner RS
    Int J Dermatol; 2003 May; 42(5):402-4. PubMed ID: 12755984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous cell carcinoma arising in a patient with long-standing pansclerotic morphea.
    Parodi PC; Riberti C; Draganic Stinco D; Patrone P; Stinco G
    Br J Dermatol; 2001 Feb; 144(2):417-9. PubMed ID: 11251587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.